Tumor promotion

From Wikipedia, the free encyclopedia

Tumor promotion is a process in carcinogenesis by which various factors permit the descendents of a single initiated cell to survive and expand in number, i.e. to resist apoptosis and to undergo clonal growth. This is a step toward tumor progression[1][2]

In order for a tumor cell to survive, it must decrease its expression of tumor suppressor genes such as p53, BRCA1, BRCA2, RB1 or the fas receptor. [3] [4] A tumor suppressor would trigger an apoptotic pathway in a cancer cell if there were DNA damage, polyploidy, or uncontrolled cell growth.

Simultaneously, tumor cells need to upregulate oncogenes, which promote or cause downstream activation of growth factors and cell survival signals such as Ras, Mitogen-activated protein kinase kinase, VEGF, or Akt. [5]

See also

References

  1. ↑ Seth Rakoff-Nahoum (Dec 2006). "Why Cancer and Inflammation?". Yale Journal of Biology and Medicine 79 (3-4): 123–130. PMC 1994795. 
  2. ↑ "NCI Dictionary of Cancer Terms:Tumor promotion". National Cancer Institute. Retrieved 10 Nov 2012. 
  3. ↑ "Tumor Suppressor Genes". 
  4. ↑ "Oncogenes, Tumor Suppressor Genes,and Cancer". American Cancer Society. 
  5. ↑ "Oncogenes, Tumor Suppressor Genes,and Cancer". American Cancer Society. 
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.